<DOC>
	<DOCNO>NCT00372372</DOCNO>
	<brief_summary>The efficacy risedronate prevention bone loss patient receive high dose corticosteroid treatment</brief_summary>
	<brief_title>The Efficacy Risedronate Prevention Bone Loss Patients Receiving High Dose Corticosteroid Treatment</brief_title>
	<detailed_description>We compare effect risedronate placebo bone mineral density change patient receive high dose corticosteroid underlie disease</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>1 . Patients various medical condition require high dose glucocorticoid treatment : ( 1 ) pulse methylprednisolone ; ( 2 ) oral prednisolone ( &gt; =0.8mg/kg/day ) equivalent least 6 week . 2 . Age &gt; =18 year &lt; 75 year . 1 . Pregnant lactating woman . 2 . Uncorrected hypocalcemia . 3 . History esophageal stricture . 4 . Previous intolerance hypersenstivity biphosphonates .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>corticosteroid , bone mineral , risedronate , bisphosphonate</keyword>
</DOC>